Cargando…
Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial
BACKGROUND: Studies evaluating titration of antihypertensive medication using self-monitoring give contradictory findings and the precise place of telemonitoring over self-monitoring alone is unclear. The TASMINH4 trial aimed to assess the efficacy of self-monitored blood pressure, with or without t...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854463/ https://www.ncbi.nlm.nih.gov/pubmed/29499873 http://dx.doi.org/10.1016/S0140-6736(18)30309-X |
_version_ | 1783306923367464960 |
---|---|
author | McManus, Richard J Mant, Jonathan Franssen, Marloes Nickless, Alecia Schwartz, Claire Hodgkinson, James Bradburn, Peter Farmer, Andrew Grant, Sabrina Greenfield, Sheila M Heneghan, Carl Jowett, Susan Martin, Una Milner, Siobhan Monahan, Mark Mort, Sam Ogburn, Emma Perera-Salazar, Rafael Shah, Syed Ahmar Yu, Ly-Mee Tarassenko, Lionel Hobbs, F D Richard |
author_facet | McManus, Richard J Mant, Jonathan Franssen, Marloes Nickless, Alecia Schwartz, Claire Hodgkinson, James Bradburn, Peter Farmer, Andrew Grant, Sabrina Greenfield, Sheila M Heneghan, Carl Jowett, Susan Martin, Una Milner, Siobhan Monahan, Mark Mort, Sam Ogburn, Emma Perera-Salazar, Rafael Shah, Syed Ahmar Yu, Ly-Mee Tarassenko, Lionel Hobbs, F D Richard |
author_sort | McManus, Richard J |
collection | PubMed |
description | BACKGROUND: Studies evaluating titration of antihypertensive medication using self-monitoring give contradictory findings and the precise place of telemonitoring over self-monitoring alone is unclear. The TASMINH4 trial aimed to assess the efficacy of self-monitored blood pressure, with or without telemonitoring, for antihypertensive titration in primary care, compared with usual care. METHODS: This study was a parallel randomised controlled trial done in 142 general practices in the UK, and included hypertensive patients older than 35 years, with blood pressure higher than 140/90 mm Hg, who were willing to self-monitor their blood pressure. Patients were randomly assigned (1:1:1) to self-monitoring blood pressure (self-montoring group), to self-monitoring blood pressure with telemonitoring (telemonitoring group), or to usual care (clinic blood pressure; usual care group). Randomisation was by a secure web-based system. Neither participants nor investigators were masked to group assignment. The primary outcome was clinic measured systolic blood pressure at 12 months from randomisation. Primary analysis was of available cases. The trial is registered with ISRCTN, number ISRCTN 83571366. FINDINGS: 1182 participants were randomly assigned to the self-monitoring group (n=395), the telemonitoring group (n=393), or the usual care group (n=394), of whom 1003 (85%) were included in the primary analysis. After 12 months, systolic blood pressure was lower in both intervention groups compared with usual care (self-monitoring, 137·0 [SD 16·7] mm Hg and telemonitoring, 136·0 [16·1] mm Hg vs usual care, 140·4 [16·5]; adjusted mean differences vs usual care: self-monitoring alone, −3·5 mm Hg [95% CI −5·8 to −1·2]; telemonitoring, −4·7 mm Hg [–7·0 to −2·4]). No difference between the self-monitoring and telemonitoring groups was recorded (adjusted mean difference −1·2 mm Hg [95% CI −3·5 to 1·2]). Results were similar in sensitivity analyses including multiple imputation. Adverse events were similar between all three groups. INTERPRETATION: Self-monitoring, with or without telemonitoring, when used by general practitioners to titrate antihypertensive medication in individuals with poorly controlled blood pressure, leads to significantly lower blood pressure than titration guided by clinic readings. With most general practitioners and many patients using self-monitoring, it could become the cornerstone of hypertension management in primary care. FUNDING: National Institute for Health Research via Programme Grant for Applied Health Research (RP-PG-1209-10051), Professorship to RJM (NIHR-RP-R2-12-015), Oxford Collaboration for Leadership in Applied Health Research and Care, and Omron Healthcare UK. |
format | Online Article Text |
id | pubmed-5854463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-58544632018-03-16 Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial McManus, Richard J Mant, Jonathan Franssen, Marloes Nickless, Alecia Schwartz, Claire Hodgkinson, James Bradburn, Peter Farmer, Andrew Grant, Sabrina Greenfield, Sheila M Heneghan, Carl Jowett, Susan Martin, Una Milner, Siobhan Monahan, Mark Mort, Sam Ogburn, Emma Perera-Salazar, Rafael Shah, Syed Ahmar Yu, Ly-Mee Tarassenko, Lionel Hobbs, F D Richard Lancet Article BACKGROUND: Studies evaluating titration of antihypertensive medication using self-monitoring give contradictory findings and the precise place of telemonitoring over self-monitoring alone is unclear. The TASMINH4 trial aimed to assess the efficacy of self-monitored blood pressure, with or without telemonitoring, for antihypertensive titration in primary care, compared with usual care. METHODS: This study was a parallel randomised controlled trial done in 142 general practices in the UK, and included hypertensive patients older than 35 years, with blood pressure higher than 140/90 mm Hg, who were willing to self-monitor their blood pressure. Patients were randomly assigned (1:1:1) to self-monitoring blood pressure (self-montoring group), to self-monitoring blood pressure with telemonitoring (telemonitoring group), or to usual care (clinic blood pressure; usual care group). Randomisation was by a secure web-based system. Neither participants nor investigators were masked to group assignment. The primary outcome was clinic measured systolic blood pressure at 12 months from randomisation. Primary analysis was of available cases. The trial is registered with ISRCTN, number ISRCTN 83571366. FINDINGS: 1182 participants were randomly assigned to the self-monitoring group (n=395), the telemonitoring group (n=393), or the usual care group (n=394), of whom 1003 (85%) were included in the primary analysis. After 12 months, systolic blood pressure was lower in both intervention groups compared with usual care (self-monitoring, 137·0 [SD 16·7] mm Hg and telemonitoring, 136·0 [16·1] mm Hg vs usual care, 140·4 [16·5]; adjusted mean differences vs usual care: self-monitoring alone, −3·5 mm Hg [95% CI −5·8 to −1·2]; telemonitoring, −4·7 mm Hg [–7·0 to −2·4]). No difference between the self-monitoring and telemonitoring groups was recorded (adjusted mean difference −1·2 mm Hg [95% CI −3·5 to 1·2]). Results were similar in sensitivity analyses including multiple imputation. Adverse events were similar between all three groups. INTERPRETATION: Self-monitoring, with or without telemonitoring, when used by general practitioners to titrate antihypertensive medication in individuals with poorly controlled blood pressure, leads to significantly lower blood pressure than titration guided by clinic readings. With most general practitioners and many patients using self-monitoring, it could become the cornerstone of hypertension management in primary care. FUNDING: National Institute for Health Research via Programme Grant for Applied Health Research (RP-PG-1209-10051), Professorship to RJM (NIHR-RP-R2-12-015), Oxford Collaboration for Leadership in Applied Health Research and Care, and Omron Healthcare UK. Elsevier 2018-03-10 /pmc/articles/PMC5854463/ /pubmed/29499873 http://dx.doi.org/10.1016/S0140-6736(18)30309-X Text en © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article McManus, Richard J Mant, Jonathan Franssen, Marloes Nickless, Alecia Schwartz, Claire Hodgkinson, James Bradburn, Peter Farmer, Andrew Grant, Sabrina Greenfield, Sheila M Heneghan, Carl Jowett, Susan Martin, Una Milner, Siobhan Monahan, Mark Mort, Sam Ogburn, Emma Perera-Salazar, Rafael Shah, Syed Ahmar Yu, Ly-Mee Tarassenko, Lionel Hobbs, F D Richard Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial |
title | Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial |
title_full | Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial |
title_fullStr | Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial |
title_full_unstemmed | Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial |
title_short | Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial |
title_sort | efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (tasminh4): an unmasked randomised controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854463/ https://www.ncbi.nlm.nih.gov/pubmed/29499873 http://dx.doi.org/10.1016/S0140-6736(18)30309-X |
work_keys_str_mv | AT mcmanusrichardj efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT mantjonathan efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT franssenmarloes efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT nicklessalecia efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT schwartzclaire efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT hodgkinsonjames efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT bradburnpeter efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT farmerandrew efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT grantsabrina efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT greenfieldsheilam efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT heneghancarl efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT jowettsusan efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT martinuna efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT milnersiobhan efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT monahanmark efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT mortsam efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT ogburnemma efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT pererasalazarrafael efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT shahsyedahmar efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT yulymee efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT tarassenkolionel efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT hobbsfdrichard efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial AT efficacyofselfmonitoredbloodpressurewithorwithouttelemonitoringfortitrationofantihypertensivemedicationtasminh4anunmaskedrandomisedcontrolledtrial |